Preparation method for chiral synthesis of high-purity levamisole hydrochloride

Through simplified synthesis routes and methods to control chiral raw materials content, environmental protection, labor protection and purity problems in synthesis of levamisazole hydrochloride are solved, and the industrial production of high-purity levamisazole hydrochloride is achieved, which is suitable for industrial production needs.

CN119039320APending Publication Date: 2024-11-29CHANGZHOU YABANG QH PHARMACHEM +2
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411100851.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-12
Publication Date
2024-11-29

Smart Images

  • Figure CN119039320A_ABST
    Figure CN119039320A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method for chiral synthesis of high-purity levamisole hydrochloride. (R)-styrene oxide is used as an initial raw material, and the (R)-styrene oxide and 2-aminothiazoline are subjected to condensation, cyclization and salification to obtain the levamisole hydrochloride. According to the invention, a chiral synthesis process is adopted, so that the working procedures of resolution and dextroisomer racemization are avoided, and the synthesis route is shortened; reaction conditions are mild, and racemization in the synthesis process is reduced; the method is simple and convenient to operate and suitable for industrial production, the optical purity can reach 99.0% or above, and the single impurity content is smaller than 0.1%. The invention also provides a key technology for controlling initial raw materials, intermediates and finished product optical isomers in the whole chiral synthesis process.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of chemistry or medicinal chemistry, and specifically relates to a preparation method of chiral synthetic high-purity levamisole hydrochloride. Background Art

[0002] Levamisole hydrochloride, CAS: 16595-80-5, chemical name: (S)-6-phenyl-2,3,5,6-tetrahydro-imidazole [2,1-B] thiazole monohydrochloride, can be used to treat infections caused by roundworms, hookworms, pinworms and Strongyloides stercoralis. Levamisole hydrochloride is the levorotatory form of tetramisole hydrochloride, and its activity is 1-2 times that of tetramisole hydrochloride (racemic form), and its toxic side effects are lower. In addition, levamisole hydrochloride also has immunomodulatory and immunostimulatory functions.

[0003] Chinese Journal of Pharmaceutical Industry, 1994, 25(8): 342. It is reported that the preparation method of levamisole hydrochloride is as follows: tetramisole hydrochloride is used as a raw material, and tetramisole is obtained by neutralization. Levamisole (the levorotatory isomer of tetramisole) is separated by using a chiral acid resolving agent (such as N-toluenesulfonyl-L-(+)-glutamic acid monosodium salt), and then salified with hydrochloric acid to obtain levamisole hydrochloride. This method also obtains dexamisole as a byproduct, and after dexamisole is racemized to tetramisole under strong alkaline conditions, it re-enters the resolving step to prepare levamisole hydrochloride. This process uses a relatively expensive chiral acid resolving agent, has a lengthy process, and has a low yield.

[0004] Shandong Pharmaceutical Industry, 1996, 15(2): 1-35. The synthesis method of racemic tetramisole hydrochloride was reported. The specific route is as follows:

[0005]

[0006] This route uses styrene oxide as the starting material and reacts in six steps to prepare tetramisole hydrochloride with a total yield of 55%. The starting material styrene oxide has a strong pungent odor, and the use of this route will cause problems in environmental protection and labor protection. In short, the method of using styrene oxide to synthesize tetramisole hydrochloride and splitting tetramisole hydrochloride to prepare levamisole hydrochloride has the disadvantages of being unfavorable to environmental protection and labor protection, lengthy procedures, large amounts of three wastes generated, and high product costs.

[0007] In view of this, scientists have been exploring chiral synthesis methods for levamisole hydrochloride, and currently there are 4 methods reported as follows:

[0008] 1) Synthesis method using chiral diamine

[0009] In 1967, Raeymaekeras et al. completed the synthesis of levamisole using chiral diamine as raw material and determined its absolute configuration, but no yield data was reported (Tetrahedron Lett. 1967, 1467-1670)

[0010]

[0011] In 2011, et al. synthesized chiral diamines by asymmetric diamination of olefins catalyzed by chiral hypervalent iodine reagents, and completed the synthesis of levamisole by the method established by Raeymaekeras et al. The entire synthesis process includes 8 steps with a total yield of 21.6% (Angew. Chem. Int. Ed. 2011, 50, 9478).

[0012] The disadvantage is that this method is expensive and difficult to adapt to large-scale production.

[0013]

[0014] 2) Asymmetric catalytic hydrogenation synthesis of α-amino ketones

[0015] In 1989, Achiwa et al. developed a method for synthesizing chiral amino alcohols by asymmetric catalytic hydrogenation of α-amino ketones to complete the synthesis of levamisole (Chem. Pharm. Bull. 1995, 43, 738). They used bromoacetophenone as a raw material, obtained the corresponding amino ketone by amino substitution reaction, and then obtained the corresponding chiral amino alcohol by rhodium catalysis (the amount of catalyst was 0.1 mol%) asymmetric catalytic hydrogenation with a yield of 96% and an enantioselectivity of 90% ee. The obtained amino alcohol was reacted with KSCN and then ring-closed in the presence of thionyl chloride to obtain levamisole. The synthesis steps are 4 steps, and the total yield is 29%. It is significantly better than the synthesis route using chiral diamines.

[0016]

[0017] 3) Synthesis of acetylated-cyano-substituted phenylethanol esterase hydrolysis

[0018] In 2005, Kamal et al. reported a method for synthesizing levamisole from (R)-β-cyanophenylethanol obtained by kinetic resolution of acetylated-cyanophenylethanol by PS-C or PS-D acetyl hydrolysis esterase (Bioorg. Med. Chem. Lett. 2005, 15, 613-615). The entire synthetic route includes 8 steps and the total yield is 19%.

[0019]

[0020] 4) Synthesis method using L-mandelic acid

[0021] CN114315866 B reports the synthesis of levamisole hydrochloride by using L-mandelic acid as the starting reactant through esterification, aminolysis, reduction, chlorination, condensation, cyclization, salt formation and other steps. The starting material L-mandelic acid of this route is expensive, the production cost is high, and industrialization cannot be achieved.

[0022]

[0023] None of the above four asymmetric synthesis methods have been used for the large-scale synthesis of levamisole. In particular, in the last step, when the (S)-hydroxy compound is chlorinated and cyclized by thionyl chloride, the stereostructure is flipped twice, which easily produces racemized isomers, resulting in about 20% of the right-handed isomer in the product, which cannot meet the optical purity requirements of levamisole hydrochloride.

[0024] Therefore, a chiral synthesis method for high-purity levamisole hydrochloride that does not require splitting, has a short synthesis route, mild reaction conditions, is easy to operate, is not prone to racemization, and is suitable for industrial production needs to be developed. Summary of the invention

[0025] The object of the present invention is to provide a chiral synthesis method of high-purity levamisole hydrochloride which does not require splitting, has a short synthesis route, mild reaction conditions, is easy to operate, is not prone to racemization, and is suitable for industrial production. The specific technical scheme is as follows:

[0026] A method for preparing chiral synthetic high-purity levamisole hydrochloride, characterized in that it is prepared via the following chemical reaction equation:

[0027]

[0028] The specific preparation steps of the above reaction equation are as follows:

[0029] (1) Condensation: adding (R)-epoxystyrene and 2-aminothiazoline in a certain ratio, adding a catalyst, heating, keeping the temperature for reaction, cooling, filtering, and obtaining a (R)-hydroxy compound;

[0030] (2) Cyclization: Add (R)-hydroxyl compound and acid-binding agent in a certain ratio to solvent A, cool down, add activator, keep warm for reaction, quench, separate layers, and concentrate the solvent to obtain levamisole;

[0031] (3) Salt formation: Add levamisole and activated carbon in a certain ratio to solvent B, increase the temperature, keep the temperature to react, filter press, add hydrochloric acid or hydrogen chloride gas to the filtrate, cool and crystallize, filter by suction, and dry to obtain levamisole hydrochloride.

[0032] In the reaction step (1), the molar ratio of the (R)-epoxystyrene to the 2-aminothiazoline feed is 1.5-8:1; the catalyst is at least one of protonic acid trifluoroacetic acid, acetic acid, formic acid, hydroiodic acid, hydrobromic acid, perchloric acid, phosphoric acid, nitric acid, and sulfuric acid, and the molar ratio of the (R)-epoxystyrene to the 2-aminothiazoline feed is 0.01-0.5:1; the insulation temperature is 40-60°C, the insulation time is 4-10 hours; and the cooling final temperature is 10-30°C.

[0033] In the reaction step (2), the solvent A is at least one of dichloromethane, dichloroethane and chloroform, and the amount thereof is 5-30 times the weight of the (R)-hydroxy compound; the acid-binding agent is at least one of triethylamine, pyridine, N,N-diisopropylethylamine, tetramethylethylenediamine, tripropylamine, 4-dimethylaminopyridine, triethylenediamine, tetrabutylammonium hydroxide and N-methylmorpholine, and the molar ratio of the amount thereof to the (R)-hydroxy compound is 0.1-1:1; The activator is at least one of p-toluenesulfonyl chloride, methylsulfonyl chloride, ethylsulfonyl chloride, propylsulfonyl chloride, butylsulfonyl chloride and allylsulfonyl chloride, and the molar ratio of the amount to the (R)-hydroxy compound is 0.1-0.8:1; the cooling temperature is -20°C-5°C; the insulation temperature is -5°C-10°C, and the insulation time is 2-8 hours; the quencher is a saturated sodium bicarbonate solution, and the amount is 2-6 times the weight of the (R)-hydroxy compound.

[0034] In the reaction step (3), the solvent B is at least one of water, methanol, ethanol, acetone and butanone, and the amount thereof is 1-5 times the weight of levamisole; the amount of activated carbon is 1%-5% of the weight of levamisole; the molar ratio of the amount of hydrochloric acid or hydrogen chloride gas to the levamisole is 1.0-1.8:1; the insulation temperature is 50°C-80°C, and the insulation time is 0.5-3 hours; and the crystallization temperature is 0°C-20°C.

[0035] Another object of the present invention is to obtain levamisole hydrochloride with a purity higher than 99.0% by weight, wherein the content of dexamisole hydrochloride is lower than 1.0%, by detecting and controlling the content of chiral raw materials and chiral intermediates in different preparation steps of levamisole hydrochloride synthesized from (R)-epoxyphenylethane as a starting material. The method comprises the following steps:

[0036] (1) detecting the optical isomer content of the starting material (R)-epoxystyrene by liquid chromatography and chiral column A, and controlling the (S)-epoxystyrene content in the (R)-epoxystyrene to be 0-2.0% w / w;

[0037] (2) detecting the optical isomer content of the intermediate (R)-hydroxy compound by liquid chromatography and chiral column B, and controlling the content of the (S)-hydroxy compound in the (R)-hydroxy compound to be 0-1.5% w / w;

[0038] (3) detecting the optical isomer content of the intermediate levamisole by liquid chromatography and chiral column B, and controlling the dexamisole content in levamisole to be 0-1.0% w / w;

[0039] (4) The optical isomer content of the finished product levamisole hydrochloride is detected by liquid chromatography and chiral column B, and the dexamisole content in the levamisole hydrochloride is controlled to be 0-1.0% w / w.

[0040] Wherein, in step (1), the chiral column A is FLM Chiral ND(2)-RH, Chiral NY(2)-RH, Chiral NS(2)-RH, Chiral NZ(2)-RH, Chiral NX(2)-RH, Chiral NQ(2)-RH, IF, IG, Ultimate Cellu-J, I A, Any ID.

[0041] In step (2), the chiral column B is Chiral MG (2), IC, IJ IK, Chiral MZ(2), ChiralGel CH / CH-R, ChiralGelBH / BH-R, IM, OX-H, Any one of OD-H, Chiral MB(2), Chiral MC(2), Chiral MD(2), Chiral MJ(2), Ultimate Cellu-DR, ChiralMX(2), Chiral MF(2), Ultimate Cellu-J, Astec Cellulose DMP.

[0042] By implementing the above key technologies for quality control in different preparation links, levamisole hydrochloride with high optical purity can be obtained.

[0043] The beneficial effects of the present invention are:

[0044] 1) The present invention adopts (R)-epoxystyrene as a starting material and avoids the steps of splitting and right-handed racemization through a chiral synthesis method, thereby shortening the synthesis route.

[0045] 2) The preparation method provided by the present invention does not use thionyl chloride for chlorination, but uses an activator instead. During the cyclization, only one stereostructure inversion occurs, thereby reducing the generation of racemization during the cyclization process.

[0046] 3) The present invention also provides a technology for controlling the optical isomers of starting materials, intermediates and finished products in the whole process of chiral synthesis. By accurately controlling the impurities and optical isomers in the starting materials and intermediates, the cost is greatly reduced and the quality of the product is improved.

[0047] 4) The preparation method provided by the present invention is easy to operate and suitable for industrial production. The optical purity can reach more than 99.0%, and the single impurity is less than 0.1%. BRIEF DESCRIPTION OF THE DRAWINGS

[0048] Figure 1 The H NMR spectrum of levamisole hydrochloride

[0049] Figure 2 The mass spectrum of levamisole hydrochloride

[0050] Figure 3 HPLC spectrum for optical purity detection of (R)-epoxyphenylethane + (S)-epoxyphenylethane

[0051] Figure 4 HPLC spectrum for optical purity detection of (R)-epoxyphenylethane

[0052] Figure 5 HPLC spectrum for optical purity detection of (R)-hydroxy compounds

[0053] Figure 6 HPLC spectrum for optical purity detection of levamisole hydrochloride

[0054] Figure 7 This is the NMR carbon spectrum of levamisole hydrochloride DETAILED DESCRIPTION

[0055] The present invention is described in detail below through specific examples. The following examples are used to explain the present invention rather than to limit the present invention.

[0056] Example 1

[0057] (1) Condensation: Add 102.2 g (1 mol) of 2-aminothiazoline and 360.5 g (3 mol) of (R)-epoxystyrene into a 1 L reaction bottle, start stirring, add 4.6 g (0.1 mol) of formic acid, raise the temperature to 60°C, and keep the temperature for 6 hours. Cool down to 20°C, filter, and rinse with 100 ml of acetone. The wet product is a white solid (R)-hydroxy compound of 174.7 g (dry weight), with a yield of 78.6%. The chiral purity of HPLC is 99.6%, and the (S)-hydroxy compound is 0.4%.

[0058] (2) Cyclization: 133.4 g (dry weight, 0.6 mol) of wet (R)-hydroxy compound and 750 g of dichloromethane were added to a 2 L reaction bottle, stirring was started, 20.2 g (0.2 mol) of triethylamine was added, the temperature was lowered to 5° C., 16.9 g of allylsulfonyl chloride (0.12 mol) was added dropwise for 2 hours, and the reaction was kept at 5° C. for 5 hours after the addition was completed, and the reaction was quenched with 200 ml of saturated sodium bicarbonate solution, separated, and the organic layer was concentrated to obtain 104.9 g of light yellow levamisole, with a yield of 85.6%. The chiral purity was 99.3% by HPLC, and the right-handed isomer was 0.7%.

[0059] (3) Salt formation: 500 g of ethanol, 102.1 g (0.5 mol) of levamisole and 3 g of activated carbon were added to a 1 L reaction bottle, the temperature was raised to 70° C., the reaction was kept warm for 0.5 hours, and the mixture was filtered. 50.7 g (0.5 mol) of hydrochloric acid was added to the filtrate, the temperature was lowered to 5° C., the mixture was filtered with suction, and the mixture was dried at 60° C. to obtain 110.9 g of levamisole hydrochloride with a yield of 93.0%. The chiral purity was 99.3% as determined by HPLC, and the dextrorotatory isomer was 0.7%.

[0060] The results of HPLC related substance detection are as follows:

[0061]

[0062]

[0063] 1 HNMR (D 2 O)δ: 3.61-3.65(m,1H),3.73-3.78(m,1H),3.81-3.86(m,1H),3.93-4.00(m,2H ),4.19-4.24(t,2H),5.68-5.71(m,1H),7.40-7.43(m,2H),7.45-7.49(m,3H). (like Figure 1 )

[0064] 13 CNMR(D 2 O)δ: 36.530, 47.942, 54.935, 67.267, 126.483, 129.270-129.383, 138.366, 176.646. (like Figure 7 )

[0065] The mass spectrum of levamisole hydrochloride obtained by the present invention:

[0066] m / z=205.07[M+H] + .(like Figure 2 )

[0067] Example 2

[0068] (1) Condensation: Add 102.2 g (1 mol) of 2-aminothiazoline and 721.0 g (6 mol) of (R)-epoxystyrene into a 1 L reaction bottle, start stirring, add 18.0 g (0.3 mol) of acetic acid, raise the temperature to 45°C, and keep the temperature for 4 hours. Cool down to 15°C, filter, and rinse with 150 ml of acetone. The wet product is a white solid (R)-hydroxy compound of 176.7 g (dry weight), with a yield of 79.5%. The chiral purity of the (S)-hydroxy compound is 0.7% as determined by HPLC.

[0069] (3) Cyclization: 133.4 g (dry weight, 0.6 mol) of wet (R)-hydroxy compound and 750 g of chloroform were added to a 2 L reaction bottle, stirring was started, 19.4 g (0.15 mol) of N,N-diisopropylethylamine was added, the temperature was lowered to 0°C, 34.4 g of methylsulfonyl chloride (0.3 mol) was added dropwise for 3 hours, and the reaction was kept at 0°C for 5 hours after the addition was completed, and the reaction was quenched with 200 ml of saturated sodium bicarbonate solution, separated, and the organic layer was concentrated to obtain 107.6 g of light yellow levamisole, with a yield of 87.8%. The chiral purity was 99.5% by HPLC, and the right-handed isomer was 0.5%.

[0070] (3) Salt formation: 500 g of acetone, 102.1 g (0.5 mol) of levamisole and 3 g of activated carbon were added to a 1 L reaction bottle, the temperature was raised to 56° C., the reaction was kept warm for 0.5 hour, and the filtrate was filtered. 32.9 g (0.9 mol) of hydrogen chloride gas was passed into the filtrate, the temperature was lowered to 10° C., suction filtered, and dried at 60° C. to obtain 112.7 g of levamisole hydrochloride with a yield of 94.5%. The chiral purity was 99.5% by HPLC, and the dextrorotatory isomer was 0.5%.

[0071] The results of HPLC related substance detection are as follows:

[0072]

[0073]

[0074] Example 3

[0075] Different manufacturers (R)-Epoxyphenylethane optical purity detection Detection Methods :

[0076] Column: Chiral NX(2)5um

[0077] Mobile phase: n-hexane: ethanol = 90:10

[0078] Flow rate: 0.5mL / min

[0079] Wavelength: 210nm

[0080] Column temperature: room temperature

[0081] Injection volume: 20uL

[0082] Running time: 30 minutes

[0083] Retention time: R type: about 10.61min; S type: about 11.46min (such as Figure 3 )

[0084] The optical purity tests of (R)-epoxystyrene from different manufacturers are as follows:

[0085] Serial number supplier (R)-Epoxyphenylene (S)-Epoxyphenylene Remark 1 Changzhou Huaren Chemical 97.6% 3.4% 2 Shanghai Fuxing 99.1% 0.9%

[0086] Example 4

[0087] Preparation of (R)-hydroxy compounds, levamisole and levamisole hydrochloride from (R)-epoxyphenylethane with different optical purity

[0088] Shanghai Fuxing (R)-epoxystyrene and racemic epoxystyrene were used in different proportions to prepare (R)-epoxystyrene samples containing different (S)-epoxystyrene amounts. The preparation method was based on Example 1. The test results are as follows:

[0089]

[0090] (R)-hydroxyl optical purity detection method:

[0091] Chromatographic column: Ultimate Cellu-DR, 250*4.6mm, 5um

[0092] Mobile phase: n-hexane: ethanol: diethylamine = 80:20:0.3

[0093] Flow rate: 0.8ml / min

[0094] Wavelength: 206nm

[0095] Injection volume: 20 μL

[0096] Running time: 40 minutes

[0097] Diluent: Methanol

[0098] Test solution: accurately weigh 100 mg of the sample into a 100 ml volumetric flask, dissolve it in diluent and dilute to the mark, shake well.

[0099] Retention time: R type: about 15.772min; S type: about 17.652min (such as Figure 5 )

[0100] Optical purity test method of levamisole and levamisole hydrochloride:

[0101] Chromatographic column: OX-H, 250*4.6mm, 5um

[0102] Mobile phase: n-hexane: ethanol = 3:7

[0103] Flow rate: 0.5ml / min

[0104] Wavelength: 210nm

[0105] Injection volume: 20 μL

[0106] Running time: 20 minutes

[0107] Diluent: Methanol

[0108] Test solution: accurately weigh 20 mg of the sample into a 100 ml volumetric flask, dissolve it in diluent and dilute to the mark, shake well.

[0109] Retention time: L-isomer: about 10.020min; D-isomer: about 9.198min (such as Figure 6 )

[0110] The present invention is not limited to the above embodiments. Any simple or equivalent changes or modifications made to the above embodiments based on the technical essence of the present invention are within the technical scope of the present invention.

Claims

1. A method for preparing chiral synthetic high-purity levamisole hydrochloride, characterized in that: Prepared by the following chemical reaction formula: The specific preparation steps of the above reaction equation are as follows: (1) Condensation: adding (R)-epoxystyrene and 2-aminothiazoline in a certain ratio, adding a catalyst, heating, keeping the temperature for reaction, cooling, filtering, and obtaining a (R)-hydroxy compound; (2) Cyclization: Add (R)-hydroxyl compound and acid-binding agent in a certain ratio to solvent A, cool down, add activator, keep warm for reaction, quench, separate layers, and concentrate the solvent to obtain levamisole; (3) Salt formation: Add levamisole and activated carbon in a certain ratio to solvent B, increase the temperature, keep the temperature to react, filter press, add hydrochloric acid or hydrogen chloride gas to the filtrate, cool and crystallize, filter by suction, and dry to obtain levamisole hydrochloride.

2. A method for preparing chiral synthetic high-purity levamisole hydrochloride, characterized in that: In different preparation steps of synthesizing levamisole hydrochloride using (R)-epoxyphenylethane as a starting material, by detecting and controlling the content of chiral raw materials and chiral intermediates, levamisole hydrochloride with a purity of more than 99.0% by weight and a dexamisole hydrochloride content of less than 1.0% is obtained. The method comprises the following steps: (1) detecting the optical isomer content of the starting material (R)-epoxystyrene by liquid chromatography and chiral column A, and controlling the (S)-epoxystyrene content in the (R)-epoxystyrene to be 0-2.0% w / w; (2) detecting the optical isomer content of the intermediate (R)-hydroxy compound by liquid chromatography and chiral column B, and controlling the content of the (S)-hydroxy compound in the (R)-hydroxy compound to be 0-1.5% w / w; (3) detecting the optical isomer content of the intermediate levamisole by liquid chromatography and chiral column B, and controlling the dexvamisole content in levamisole to be 0-1.0% w / w; (4) The optical isomer content of the finished product levamisole hydrochloride is detected by liquid chromatography and chiral column B, and the dexamisole content in the levamisole hydrochloride is controlled to be 0-1.0% w / w.

3. The method for preparing chiral synthetic high-purity levamisole hydrochloride according to claim 1, characterized in that: In the reaction step (1), the molar ratio of the (R)-epoxystyrene to the 2-aminothiazoline feed is 1.5-8:1; the catalyst is at least one of protonic acid trifluoroacetic acid, acetic acid, formic acid, hydroiodic acid, hydrobromic acid, perchloric acid, phosphoric acid, nitric acid, and sulfuric acid, and the molar ratio of the (R)-epoxystyrene to the 2-aminothiazoline feed is 0.01-0.5:1; the insulation temperature is 40-60°C, the insulation time is 4-10 hours; and the cooling final temperature is 10-30°C.

4. The method for preparing chiral synthetic high-purity levamisole hydrochloride according to claim 1, characterized in that: In the reaction step (2), the solvent A is at least one of dichloromethane, dichloroethane and chloroform, and the amount thereof is 5-30 times the weight of the (R)-hydroxy compound; the acid-binding agent is at least one of triethylamine, pyridine, N,N-diisopropylethylamine, tetramethylethylenediamine, tripropylamine, 4-dimethylaminopyridine, triethylenediamine, tetrabutylammonium hydroxide and N-methylmorpholine, and the molar ratio of the amount thereof to the (R)-hydroxy compound is 0.1-1:1; The activator is at least one of p-toluenesulfonyl chloride, methylsulfonyl chloride, ethylsulfonyl chloride, propylsulfonyl chloride, butylsulfonyl chloride and allylsulfonyl chloride, and the molar ratio of the amount to the (R)-hydroxy compound is 0.1-0.8:1; the cooling temperature is -20°C-5°C; the insulation temperature is -5°C-10°C, and the insulation time is 2-8 hours; the quencher is a saturated sodium bicarbonate solution, and the amount is 2-6 times the weight of the (R)-hydroxy compound.

5. The method for preparing chiral synthetic high-purity levamisole hydrochloride according to claim 1, characterized in that: In the reaction step (3), the solvent B is at least one of water, methanol, ethanol, acetone and butanone, and the amount thereof is 1-5 times the weight of levamisole; the amount of activated carbon is 1%-5% of the weight of levamisole; the molar ratio of the amount of hydrochloric acid or hydrogen chloride gas to the levamisole is 1.0-1.8:1; the insulation temperature is 50°C-80°C, and the insulation time is 0.5-3 hours; and the crystallization temperature is 0°C-20°C.

6. The method for preparing chiral synthetic high-purity levamisole hydrochloride according to claim 2, characterized in that: In step (1), the chiral column A is FLM Chiral ND(2)-RH, Chiral NY(2)-RH, Chiral NS(2)-RH, Chiral NZ(2)-RH, Chiral NX(2)-RH, Chiral NQ(2)-RH, Ultimate Cellu-J, Any one of .

7. The method for preparing chiral synthetic high-purity levamisole hydrochloride according to claim 2, characterized in that: In step (2), the chiral column B is Chiral MG (2), Chiral MZ(2), ChiralGel CH / CH-R, ChiralGelBH / BH-R, OX-H, Any one of ChiralMB(2), Chiral MC(2), Chiral MD(2), Chiral MJ(2), Ultimate Cellu-DR, Chiral MX(2), Chiral MF(2), Ultimate Cellu-J, Astec Cellulose DMP.